Phase 2 open-label study of pembrolizumab plus lenvatinib and belzutifan in patients with advanced solid tumors Meeting Abstract
| Authors: | Kelley, R. K.; Van Cutsem, E.; Lee, M. S.; Wolf, I.; Fakih, M.; De Vos-Geelen, J. D.; Lee, V.; Vogel, A.; Wu, L.; Jin, F.; Naik, G. S.; O'Reilly, E. M. |
| Abstract Title: | Phase 2 open-label study of pembrolizumab plus lenvatinib and belzutifan in patients with advanced solid tumors |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304927 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS4173 |
| Notes: | Meeting Abstract: TPS4173 -- Meeting also held virtually -- Source: Wos |
